ACR: Duloxetine Falls Short in Phase III Fibromyalgia Trial – MedPage Today

by General Manager on 12th November 2007

in All ME/ Chronic Fatigue Syndrome And Fibromyalgia News, Research

ACR: Duloxetine Falls Short in Phase III Fibromyalgia Trial
MedPage Today, NJ - Nov 10, 2007
10 — Duloxetine (Cymbalta) has apparently stumbled on its quest for approval as an agent against pain and other symptoms of fibromyalgia.

{ 1 comment… read it below or add one }

Sarah 13th November 2007 at 9:34 pm

I tried the cymbalta to combat my fibromyalgia for 2 years and found very little benefit for me. It helps with the pain you deal with on a daily basis, but has a tendency to put your emotions on hold. I feel better mentally since I stopped taking the cymbalta.. now I am just hoping they can find something else for the darn pain!!

Leave a Comment

Previous post: Fralex Announces Fiscal 2007 Third Quarter Results – Canada NewsWire (press release)

Next post: Exercise May Help Fibromyalgia Patients – Associated Content